Anders Sundin

13PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)English and literacy curriculum and pedagogy (excl. LOTE, ESL and TESOL)Solid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 29, 2026
Tumor microenvironment gene engineering with LOAd703 in patients with solid malignancies: LOKON002 phase I/IIb clinical trial.

|Apr 09, 2024
Prevalence of metastases outside the liver and abdominal lymph nodes on <sup>68</sup>Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours.

Maria Wedin, Eva Tiensuu Janson, Göran Wallin

|Mar 13, 2024
Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients.

Dimitrios Papantoniou, Katarzyna Fröss-Baron, Ulrike Garske-Román

|Dec 14, 2023
Use and perceived utility of [<sup>18</sup> F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.

Valentina Ambrosini, Martyn Caplin, Justo P Castaño

|Oct 09, 2023
Improved health-related quality of life during peptide receptor radionuclide therapy in patients with neuroendocrine tumours.

Katarina Edfeldt, Per Hellman, Dan Granberg

|Jul 04, 2023
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1-G3.

Francesco Panzuto, John Ramage, D Mark Pritchard

Pageof 3

Frequent Collaborators

3 joint publications

Clarisse Dromain

2 joint publications

Rodney J Hicks

2 joint publications

Wouter W de Herder

2 joint publications

Anna Koumarianou